SALT LAKE CITY--(BUSINESS WIRE)--Foldax®, Inc. today announced that the first patients have been enrolled in the Drugs Controller General of India (DCGI)-approved clinical trial of the TRIA™ ...
SALT LAKE CITY--(BUSINESS WIRE)--Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced positive 30-day results from a prospective, multicenter, single-arm, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback